Home > Result Summaries: Compounds > GSK1362885 Result Summaries: GSK1362885 GSKStudy ID Phase Title Summary (Download) 111497 phase 1 A single-blind, randomized, placebo controlled, ascending single dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK1362885 in healthy normal subjects. (0 citation(s)) 111823 phase 1 A Randomized, Open-Label Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics ofGSK1362885 in Subjects with Type 2 Diabetes Mellitus (0 citation(s))
